UPDATE 1-Amgen revenue falls slightly as Lilly COVID deal contributes less
Yahoo! Finance
Amgen Inc on Tuesday said its fourth-quarter revenue fell slightly as a 4% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co. Amgen reported revenue of $6.84 billion for the quarter, down from $6.85 billion a year ago, but ahead of analysts' estimates of $6.77 billion, according to Refinitiv data. Amgen partnered with Lilly in 2020 to increase the supply of its COVID-19 antibody treatments.
Continue Reading